{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:05:06Z","timestamp":1790787906253,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11095-020-02808-w","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:04:05Z","timestamp":1589209445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Organogel Nanoparticles as a New Way to Improve Oral Bioavailability of Poorly Soluble Compounds"],"prefix":"10.1007","volume":"37","author":[{"given":"Baptiste","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislain","family":"Garrait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Beyssac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Goudouneche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"2808_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1023\/A:1021368007777","volume":"5","author":"TI Oprea","year":"2000","unstructured":"Oprea TI. Current trends in lead discovery: are we looking for the appropriate properties? Mol Divers. 2000;5:199\u2013208.","journal-title":"Mol Divers"},{"key":"2808_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23:3\u201325.","journal-title":"Adv Drug Deliv Rev"},{"key":"2808_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.drudis.2011.11.007","volume":"17","author":"L Di","year":"2012","unstructured":"Di L, Fish PV, Mano T. Bridging solubility between drug discovery and development. Drug Discov Today. 2012;17:486\u201395. https:\/\/doi.org\/10.1016\/j.drudis.2011.11.007.","journal-title":"Drug Discov Today"},{"key":"2808_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1208\/s12248-011-9290-9","volume":"13","author":"LZ Benet","year":"2011","unstructured":"Benet LZ, Broccatelli F, Oprea TI. BDDCS applied to over 900 drugs. AAPS J. 2011;13:519\u201347. https:\/\/doi.org\/10.1208\/s12248-011-9290-9.","journal-title":"AAPS J"},{"key":"2808_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1124\/pr.112.005660","volume":"65","author":"HD Williams","year":"2013","unstructured":"Williams HD, Trevaskis NL, Charman SA, Shanker RM, Charman WN, Pouton CW, et al. Strategies to address low drug solubility in discovery and development. Pharmacol Rev. 2013;65:315\u2013499. https:\/\/doi.org\/10.1124\/pr.112.005660.","journal-title":"Pharmacol Rev"},{"key":"2808_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","volume":"5","author":"S Kalepu","year":"2015","unstructured":"Kalepu S, Nekkanti V. Insoluble drug delivery strategies: review of recent advances and business prospects. Acta Pharm Sin B. 2015;5:442\u201353. https:\/\/doi.org\/10.1016\/j.apsb.2015.07.003.","journal-title":"Acta Pharm Sin B"},{"key":"2808_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nrd2197","volume":"6","author":"CJH Porter","year":"2007","unstructured":"Porter CJH, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov. 2007;6:231\u201348. https:\/\/doi.org\/10.1038\/nrd2197.","journal-title":"Nat Rev Drug Discov"},{"key":"2808_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijpharm.2013.03.054","volume":"453","author":"H Mu","year":"2013","unstructured":"Mu H, Holm R, M\u00fcllertz A. Lipid-based formulations for oral administration of poorly water-soluble drugs. Int J Pharm. 2013;453:215\u201324. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.03.054.","journal-title":"Int J Pharm"},{"key":"2808_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"F Kesisoglou","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y. Nanosizing \u2014 Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59:631\u201344. https:\/\/doi.org\/10.1016\/j.addr.2007.05.003.","journal-title":"Adv Drug Deliv Rev"},{"key":"2808_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1177\/0192623307310946","volume":"36","author":"EM Merisko-Liversidge","year":"2008","unstructured":"Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol. 2008;36:43\u20138. https:\/\/doi.org\/10.1177\/0192623307310946.","journal-title":"Toxicol Pathol"},{"key":"2808_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","volume":"366","author":"J Pardeike","year":"2009","unstructured":"Pardeike J, Hommoss A, M\u00fcller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170\u201384.","journal-title":"Int J Pharm"},{"key":"2808_CR12","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/10408398.2011.559558","volume":"51","author":"DJ McClements","year":"2011","unstructured":"McClements DJ, Rao J. Food-grade Nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity. Crit Rev Food Sci Nutr. 2011;51:285\u2013330. https:\/\/doi.org\/10.1080\/10408398.2011.559558.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"2808_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cis.2003.10.023","volume":"108\u2013109","author":"T Tadros","year":"2004","unstructured":"Tadros T, Izquierdo P, Esquena J, Solans C. Formation and stability of nano-emulsions. Adv Colloid Interf Sci. 2004;108\u2013109:303\u201318.","journal-title":"Adv Colloid Interf Sci"},{"key":"2808_CR14","doi-asserted-by":"publisher","first-page":"S131","DOI":"10.1016\/S0169-409X(02)00118-7","volume":"54","author":"RH M\u00fcller","year":"2002","unstructured":"M\u00fcller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54:S131\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"2808_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0939-6411(98)00074-5","volume":"47","author":"C Freitas","year":"1999","unstructured":"Freitas C, M\u00fcller RH. Correlation between long-term stability of solid lipid nanoparticles (SLN\u2122) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 1999;47:125\u201332.","journal-title":"Eur J Pharm Biopharm"},{"key":"2808_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejps.2012.05.010","volume":"47","author":"S Das","year":"2012","unstructured":"Das S, Ng WK, Tan RBH. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur J Pharm Sci. 2012;47:139\u201351.","journal-title":"Eur J Pharm Sci"},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.colsurfa.2008.06.011","volume":"328","author":"P Kirilov","year":"2008","unstructured":"Kirilov P, Lukyanova L, Franceschi-Messant S, Perier V, Perez E, Rico-Lattes I. A new type of colloidal dispersions based on nanoparticles of gelled oil. Colloids Surf Physicochem Eng Asp. 2008;328:1\u20137.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"2808_CR18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1208\/s12249-016-0587-y","volume":"18","author":"B Martin","year":"2017","unstructured":"Martin B, Brouillet F, Franceschi S, Perez E. Evaluation of Organogel nanoparticles as drug delivery system for lipophilic compounds. AAPS PharmSciTech. 2017;18:1261\u20139. https:\/\/doi.org\/10.1208\/s12249-016-0587-y.","journal-title":"AAPS PharmSciTech"},{"key":"2808_CR19","unstructured":"European Pharmacopoeia, 8th ed., European Directorate for the Quality of Medicines & Healthcare, Council of Europe, Strasbourg, France, 2012."},{"key":"2808_CR20","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1021\/jf053169a","volume":"54","author":"G Garrait","year":"2006","unstructured":"Garrait G, Jarrige JF, Blanquet S, Beyssac E, Cardot JM, Alric M. Gastrointestinal absorption and urinary excretion of trans -Cinnamic and p -Coumaric acids in rats. J Agric Food Chem. 2006;54:2944\u201350. https:\/\/doi.org\/10.1021\/jf053169a.","journal-title":"J Agric Food Chem"},{"key":"2808_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14227\/DT210214P31","volume":"21","author":"EC Pinto","year":"2014","unstructured":"Pinto EC, Cabral LM, de Sousa VP. Development of a Discriminative Intrinsic Dissolution Method for Efavirenz. Dissolution Technol. 2014;21:31\u201340. https:\/\/doi.org\/10.14227\/DT210214P31.","journal-title":"Dissolution Technol"},{"key":"2808_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ijpharm.2005.10.044","volume":"309","author":"V Papadopoulou","year":"2006","unstructured":"Papadopoulou V, Kosmidis K, Vlachou M, Macheras P. On the use of the Weibull function for the discernment of drug release mechanisms. Int J Pharm. 2006;309:44\u201350. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.044.","journal-title":"Int J Pharm"},{"key":"2808_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijpharm.2009.04.046","volume":"377","author":"S K\u00fcchler","year":"2009","unstructured":"K\u00fcchler S, Abdel-Mottaleb M, Lamprecht A, Radowski MR, Haag R, Sch\u00e4fer-Korting M. Influence of nanocarrier type and size on skin delivery of hydrophilic agents. Int J Pharm. 2009;377:169\u201372. https:\/\/doi.org\/10.1016\/j.ijpharm.2009.04.046.","journal-title":"Int J Pharm"},{"key":"2808_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.4.4.395","volume":"4","author":"H Sun","year":"2008","unstructured":"Sun H, Chow EC, Liu S, Du Y, Pang KS. The Caco-2 cell monolayer: usefulness and limitations. Expert Opin Drug Metab Toxicol. 2008;4:395\u2013411. https:\/\/doi.org\/10.1517\/17425255.4.4.395.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2808_CR25","doi-asserted-by":"publisher","first-page":"9573","DOI":"10.1021\/jp9001516","volume":"113","author":"M Mahmoudi","year":"2009","unstructured":"Mahmoudi M, Simchi A, Imani M. Cytotoxicity of uncoated and polyvinyl alcohol coated superparamagnetic iron oxide nanoparticles. J Phys Chem C. 2009;113:9573\u201380.","journal-title":"J Phys Chem C"},{"key":"2808_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejpb.2011.03.022","volume":"79","author":"S Petersen","year":"2011","unstructured":"Petersen S, Steiniger F, Fischer D, Fahr A, Bunjes H. The physical state of lipid nanoparticles influences their effect on in vitro cell viability. Eur J Pharm Biopharm. 2011;79:150\u201361. https:\/\/doi.org\/10.1016\/j.ejpb.2011.03.022.","journal-title":"Eur J Pharm Biopharm"},{"key":"2808_CR27","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3109\/02652048.2010.506582","volume":"27","author":"A Boudier","year":"2010","unstructured":"Boudier A, Kirilov P, Franceschi-Messant S, Haouaria B, Hadioui L, Roques R, et al. Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs. J Microencapsul. 2010;27:682\u201392.","journal-title":"J Microencapsul"},{"key":"2808_CR28","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.biomaterials.2010.11.082","volume":"32","author":"DA Chiappetta","year":"2011","unstructured":"Chiappetta DA, Hocht C, Taira C, Sosnik A. Oral pharmacokinetics of the anti-HIV efavirenz encapsulated within polymeric micelles. Biomaterials. 2011;32:2379\u201387. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.11.082.","journal-title":"Biomaterials."},{"key":"2808_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/jps.2600520629","volume":"52","author":"JG Wagner","year":"1963","unstructured":"Wagner JG, Nelson E. Per cent absorbed time plots derived from blood level and\/or urinary excretion data. J Pharm Sci. 1963;52:610\u20131.","journal-title":"J Pharm Sci"},{"key":"2808_CR30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1081\/PDT-120017518","volume":"8","author":"SM Bahal","year":"2003","unstructured":"Bahal SM, Romansky JM, Alvarez FJ. Medium chain triglycerides as vehicle for palatable Oral liquids. Pharm Dev Technol. 2003;8:111\u20135.","journal-title":"Pharm Dev Technol"},{"key":"2808_CR31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/03639045.2012.746362","volume":"40","author":"GV Patel","year":"2014","unstructured":"Patel GV, Patel VB, Pathak A, Rajput SJ. Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation. Drug Dev Ind Pharm. 2014;40:80\u201391. https:\/\/doi.org\/10.3109\/03639045.2012.746362.","journal-title":"Drug Dev Ind Pharm"},{"key":"2808_CR32","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1166\/jbn.2013.1683","volume":"9","author":"S Jain","year":"2013","unstructured":"Jain S, Sharma JM, Agrawal AK, Mahajan RR. Surface stabilized Efavirenz nanoparticles for Oral bioavailability enhancement. J Biomed Nanotechnol. 2013;9:1862\u201374. https:\/\/doi.org\/10.1166\/jbn.2013.1683.","journal-title":"J Biomed Nanotechnol"},{"key":"2808_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.colsurfb.2014.12.014","volume":"126","author":"AM Avachat","year":"2015","unstructured":"Avachat AM, Parpani SS. Formulation and development of bicontinuous nanostructured liquid crystalline particles of efavirenz. Colloids Surf B Biointerfaces. 2015;126:87\u201397. https:\/\/doi.org\/10.1016\/j.colsurfb.2014.12.014.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"2808_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.ijpharm.2015.09.014","volume":"495","author":"V Makwana","year":"2015","unstructured":"Makwana V, Jain R, Patel K, Nivsarkar M, Joshi A. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: elucidation of mechanism of uptake using chylomicron flow blocking approach. Int J Pharm. 2015;495:439\u201346. https:\/\/doi.org\/10.1016\/j.ijpharm.2015.09.014.","journal-title":"Int J Pharm"},{"key":"2808_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2217\/nnm.09.90","volume":"5","author":"DA Chiappetta","year":"2010","unstructured":"Chiappetta DA, Hocht C, Taira C, Sosnik A. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability. Nanomed. 2010;5:11\u201323. https:\/\/doi.org\/10.2217\/nnm.09.90.","journal-title":"Nanomed."},{"key":"2808_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2013.07.001","volume":"8","author":"L Kou","year":"2013","unstructured":"Kou L, Sun J, Zhai Y, He Z. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci. 2013;8:1\u201310. https:\/\/doi.org\/10.1016\/j.ajps.2013.07.001.","journal-title":"Asian J Pharm Sci"},{"key":"2808_CR37","doi-asserted-by":"crossref","unstructured":"S. Snipstad, S. Westr\u00f8m, Y. M\u00f8rch, M. Afadzi, A. K. A. Aslund C . De Lange Davies, Contact-mediated intracellular delivery of hydrophobic drugs from polymeric nanoparticles, Cancer Nanotechnol. 5 (2014) 1.","DOI":"10.1186\/s12645-014-0008-4"},{"key":"2808_CR38","doi-asserted-by":"publisher","first-page":"11876","DOI":"10.1039\/c2ra21544f","volume":"2","author":"AS Klymchenko","year":"2012","unstructured":"Klymchenko AS, Roger E, Anton N, Anton H, Shulov I, Vermot J, et al. Highly lipophilic fluorescent dyes in nano-emulsions: towards bright non-leaking nano-droplets. RSC Adv. 2012;2:11876\u201386. https:\/\/doi.org\/10.1039\/c2ra21544f.","journal-title":"RSC Adv"},{"key":"2808_CR39","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1039\/C3CC48130A","volume":"50","author":"D Hofmann","year":"2014","unstructured":"Hofmann D, Messerschmidt C, Bannwarth MB, Landfester K, Mail\u00e4nder V. Drug delivery without nanoparticle uptake: delivery by a kiss-and-run mechanism on the cell membrane. Chem Commun. 2014;50:1369\u201371. https:\/\/doi.org\/10.1039\/C3CC48130A.","journal-title":"Chem Commun"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02808-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-020-02808-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-020-02808-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T23:50:23Z","timestamp":1620690623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-020-02808-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1007\/s11095-020-02808-w","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"5 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"92"}}